Acadia Pharmaceuticals (ACAD) Debt Ratio (2010 - 2012)

Acadia Pharmaceuticals' (ACAD) quarterly Debt Ratio came in at 0.0 in Q1 2012, down 16.75% quarter-over-quarter from 0.0 in Q4 2011.

Acadia Pharmaceuticals (ACAD) Debt Ratio (2010 - 2012) Analysis & Trends

Acadia Pharmaceuticals' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q1 2012.

  • On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.0 in Q1 2012; TTM through Mar 2012 was 0.0, a N/A change from a year earlier, with the FY2011 full-year figure at 0.0, down 50.95% from the prior year.
  • Debt Ratio slipped to 0.0 in Q1 2012 per ACAD's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.0 in Q4 2010 and bottomed at 0.0 in Q1 2012.
  • The 3-year median for Debt Ratio is 0.0 (2011), against an average of 0.0.
  • Biggest YoY gain for Debt Ratio was 50.95% in 2011; the steepest drop was 50.95% in 2011.
  • Year by year, Debt Ratio stood at 0.0 in 2010, then plunged by 50.95% to 0.0 in 2011, then decreased by 16.75% to 0.0 in 2012.
  • Per Business Quant, the three latest ACAD Debt Ratio figures stand at 0.0 (Q1 2012), 0.0 (Q4 2011), and 0.0 (Q3 2011).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Acadia Pharmaceuticals 4.23 Bn 3.38 Bn 243.27 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2012 0.00
Dec 31, 2011 0.00
Sep 30, 2011 0.00
Jun 30, 2011 0.00
Dec 31, 2010 0.00